The Latest Breaking News from Purdue

From household names to hopeful teenagers making their Olympic debut, these are the British athletes to look out for in Paris

OxyContin maker Purdue Pharma, the family that owns it and lawyers for thousands of parties with claims against it are getting ready to work on a new settlement after the U.S. Supreme Court rejected the last one

The US Supreme Court on Thursday rejected Purdue Pharma's $6 billion opioids settlement immunizing the Sackler family, which controlled the drugmaker, from future litigation.

The majority and the dissenters agree that the drug was "central" to "the opioid crisis," even though there is little evidence to support that thesis.

The Supreme Court ruled 5-4 against an estimated US$6 billion Purdue Pharma bankruptcy plan on June 27, 2024, that would have shielded the Sackler family – which owned and controlled the company – from legal liability.

The US Supreme Court on Thursday rejected OxyContin maker Purdue Pharma's $6 billion settlement that would have shielded the Sackler family, who owned the company and earned tens of billions as it flooded the country with the highly addictive drug, from future civil lawsuits over the role they played in…

The Supreme Court has rejected a settlement for OxyContin maker Purdue Pharma and members of the Sackler family who own the company

Controversial deal would have protected billionaire family owners from further liability over US opioid epidemic

The 5-4 opinion will send victims of the opioid crisis back to settlement negotiations with the company and the Sackler family.